[go: up one dir, main page]

NO20015172L - 1-methyl-erythromycin derivatives - Google Patents

1-methyl-erythromycin derivatives

Info

Publication number
NO20015172L
NO20015172L NO20015172A NO20015172A NO20015172L NO 20015172 L NO20015172 L NO 20015172L NO 20015172 A NO20015172 A NO 20015172A NO 20015172 A NO20015172 A NO 20015172A NO 20015172 L NO20015172 L NO 20015172L
Authority
NO
Norway
Prior art keywords
methyl
compounds
formula
erythromycin derivatives
disclosed
Prior art date
Application number
NO20015172A
Other languages
Norwegian (no)
Other versions
NO20015172D0 (en
Inventor
John Philip Dirlam
Takushi Kaneko
Wei-Guo Su
Young-Jin Wu
Hamish Alastair Irvin Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20015172D0 publication Critical patent/NO20015172D0/en
Publication of NO20015172L publication Critical patent/NO20015172L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Det er beskrevet forbindelser med formel (1) og farmasøytisk akseptable salter, promedikamenter og solvater derav, hvor R1, R2, R3, R4, R5, R17, Rf, A, X og Y er som definert heri. Det er også beskrevet farmasøytiske preparater inneholdende forbindelsene med formel (1), fremgangsmåter for anvendelse av forbindelsene med formel (1) for behandling av infeksjoner og metoder for å fremstille forbindelsene med formel (1).Compounds of formula (1) and pharmaceutically acceptable salts, prodrugs and solvates thereof are disclosed, wherein R1, R2, R3, R4, R5, R17, Rf, A, X and Y are as defined herein. Also disclosed are pharmaceutical compositions containing the compounds of formula (1), methods of using the compounds of formula (1) for the treatment of infections, and methods of preparing the compounds of formula (1).

NO20015172A 1999-05-24 2001-10-23 1-methyl-erythromycin derivatives NO20015172L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13546899P 1999-05-24 1999-05-24
PCT/IB2000/000502 WO2000071557A1 (en) 1999-05-24 2000-04-25 13-methyl-erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO20015172D0 NO20015172D0 (en) 2001-10-23
NO20015172L true NO20015172L (en) 2002-01-23

Family

ID=22468240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015172A NO20015172L (en) 1999-05-24 2001-10-23 1-methyl-erythromycin derivatives

Country Status (32)

Country Link
US (2) US20030100518A1 (en)
EP (1) EP1180110A1 (en)
JP (1) JP2003500414A (en)
KR (1) KR20020016799A (en)
CN (1) CN1351608A (en)
AP (1) AP2001002302A0 (en)
AR (1) AR020032A1 (en)
AU (1) AU3832100A (en)
BG (1) BG106127A (en)
BR (1) BR0010938A (en)
CA (1) CA2373117C (en)
CZ (1) CZ20013733A3 (en)
DZ (1) DZ3045A1 (en)
EA (1) EA200100983A1 (en)
EE (1) EE200100613A (en)
HK (1) HK1045523A1 (en)
HR (1) HRP20010866A2 (en)
HU (1) HUP0201516A3 (en)
IL (1) IL145739A0 (en)
IS (1) IS6128A (en)
MA (1) MA26740A1 (en)
NO (1) NO20015172L (en)
OA (1) OA11945A (en)
PA (1) PA8495101A1 (en)
PE (1) PE20010171A1 (en)
PL (1) PL352720A1 (en)
SK (1) SK15162001A3 (en)
TN (1) TNSN00108A1 (en)
TR (1) TR200103395T2 (en)
UY (1) UY26161A1 (en)
WO (1) WO2000071557A1 (en)
ZA (1) ZA200109595B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
OA11670A (en) * 1998-11-03 2005-01-12 Pfizer Prod Inc Novel macrolide antibiotics.
ID30233A (en) 1999-01-27 2001-11-15 Pfizer Prod Inc ANTIBIOTICS OF TETOLIDA
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
JP2002542197A (en) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Ketolide antibacterial agent
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
DE60030847T2 (en) 1999-04-16 2007-04-19 Kosan Biosciences, Inc., Hayward ANTI-INFECTIOUS MAKROLIDE DERIVATIVES
CN1351608A (en) 1999-05-24 2002-05-29 辉瑞产品公司 13-Methylerythromycin Derivatives
PT1167376E (en) 2000-06-30 2004-09-30 Pfizer Prod Inc MACROLIDOS ANTIBIOTICS
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
RU2004117082A (en) 2001-12-05 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) KETOLIDE 6-0-ACYL DERIVATIVES OF ERYTHROMYCIN AS ANTIBACTERIAL MEANS
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
MXPA04010556A (en) * 2002-04-25 2005-02-17 Abbott Lab Oxolide antibacterials.
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
HRP20100253T1 (en) 2004-12-21 2010-06-30 Pfizer Products Inc. macrolides
CN101568343A (en) 2006-06-12 2009-10-28 雷蒙特亚特特拉维夫大学有限公司 Methods for treating cancer
CN101175322B (en) * 2007-11-16 2010-12-15 华为技术有限公司 A Method of Cell Selection
KR101043637B1 (en) * 2009-07-13 2011-06-24 태석정공 주식회사 Combined Structure of Camera Module of Portable Dual Monitor
AR085286A1 (en) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd MACROLIDO DERIVATIVE REPLACED IN POSITION C-4
MD20150056A2 (en) 2012-12-24 2015-09-30 Ramot At Tel-Aviv University Ltd Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CA2963815A1 (en) * 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
HK1250371A1 (en) 2015-03-25 2018-12-14 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US13665A (en) * 1855-10-09 Daguerreotype-plate holder
US111317A (en) * 1871-01-31 Improvement in culinary vessels
US13662A (en) * 1855-10-09 Improvement in sewing-machines
US52328A (en) * 1866-01-30 Improved mode of attaching car-wheels to axles
US50254A (en) * 1865-10-03 Improvement in portable scales
US77302A (en) * 1868-04-28 mat son
US100742A (en) * 1870-03-15 Improvement in lawn-mowers
US100518A (en) * 1870-03-08 Roland s
US40007A (en) * 1863-09-22 Improvement in railroad-car brakes
US156027A (en) * 1874-10-20 Improvement in loom-shuttles
US25937A (en) * 1859-11-01 ballou
US13281A (en) * 1855-07-17 Churn
US61858A (en) * 1867-02-05 Improved washing machine
US61856A (en) * 1867-02-05 Enos s
US61857A (en) * 1867-02-05 Improvement in top-drivers or spinners
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (en) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6-0-methylerythromycin A derivative
JPS61229895A (en) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd Protected des-n-methylerythromycin derivative
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
DE3860503D1 (en) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-DIHYDRO-10-DEOXO-11-AZAERYTHRONOLID-A COMPOUNDS, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS AND THE PRODUCTION THEREOF.
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US6060234A (en) 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (en) 1992-05-21 1995-06-02 Roussel Uclaf New derivatives of 1-oxa 6-azacyclopentadecane 13,15-dione, their preparation process and their use as medicaments.
US5414926A (en) * 1992-10-09 1995-05-16 Sumitomo Wiring Systems, Ltd. Terminal crimping apparatus
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (en) * 1992-11-05 1994-12-23 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (en) * 1993-03-09 1995-04-28 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
FR2719587B1 (en) * 1994-05-03 1996-07-12 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
FR2727969B1 (en) * 1994-12-09 1997-01-17 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2732023B1 (en) 1995-03-22 1997-04-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2732684B1 (en) 1995-04-06 1997-04-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
FR2742757B1 (en) * 1995-12-22 1998-01-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2745290B1 (en) * 1996-02-28 1998-04-03 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
CZ351898A3 (en) * 1996-05-07 1999-04-14 Abbott Laboratories 6-O-substituted erythromycin compounds and a process for their preparation
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
JP2000509712A (en) * 1996-05-07 2000-08-02 アボツト・ラボラトリーズ 6-O-substituted erythromycin and method for producing the same
FR2748746B1 (en) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc NEW PROCESS FOR ISOMERIZATION OF RADICAL METHYL IN 10 FROM ERYTHROMYCIN DERIVATIVES
DE19626036A1 (en) 1996-06-28 1998-01-02 Whitaker Corp Optical connector
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
CN1179046C (en) 1996-07-05 2004-12-08 拜奥蒂卡技术有限公司 Novel erythromycin, its preparation method, use and pharmaceutical composition containing it
FR2751656B1 (en) 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
UA51730C2 (en) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-0-substituted ketolides having antibacterial activity
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
FR2754821B1 (en) 1996-10-23 2003-04-04 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
WO1998023628A1 (en) * 1996-11-27 1998-06-04 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
FR2757168B1 (en) 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2760017B1 (en) 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc NOVEL ERYTROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
KR20010013660A (en) 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-oxime erythromycin derivatives
HN1998000086A (en) * 1997-06-11 1999-03-08 Pfizer Prod Inc DERIVATIVES OF 9 - DESOFO - 9 AZA - 9A - HOMOERITROMICINA A - C - 4 SUBSTITUTED.
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US5868549A (en) * 1997-08-29 1999-02-09 Hk Systems, Inc. Palletizer with air assisted slide plate assembly and indexing pallet hoist
PA8461401A1 (en) * 1997-10-29 2000-05-24 Pfizer Prod Inc TRICYCLIC ERYTHROMYCINE DERIVATIVES
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
AU1504899A (en) 1997-12-11 1999-06-28 Hokuriku Seiyaku Co. Ltd Erythromycin derivatives
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
ATE275151T1 (en) * 1998-03-03 2004-09-15 Pfizer Prod Inc 3,6-KETAL MACROLIDA ANTIBIOTIC
FR2777282B1 (en) 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc NEW DERIVATIVES OF 2-FLUORO 3-DE ((2,6-DIDEOXY 3-C-METHYL 3-0-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL) OXYL) 6-O-METHYL 3-OXO ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE SYNTHESIS OF ACTIVE INGREDIENTS OF MEDICINES
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
ATE298761T1 (en) * 1998-09-22 2005-07-15 Pfizer Prod Inc CARBAMAT AND CARBAZATE KETOLID ANTIBIOTICS
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
FR2785612A1 (en) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc NOVEL DERIVATIVES OF ERYTHROMYCIN, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
OA11670A (en) 1998-11-03 2005-01-12 Pfizer Prod Inc Novel macrolide antibiotics.
UA70972C2 (en) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-membered azalides and use thereof as antibiotics
FR2786188B1 (en) 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
ID30233A (en) 1999-01-27 2001-11-15 Pfizer Prod Inc ANTIBIOTICS OF TETOLIDA
FR2789392B1 (en) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
JP2002542197A (en) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Ketolide antibacterial agent
US20020061857A1 (en) 1999-04-23 2002-05-23 Yong-Jin Wu 9-amino-3-oxo erythromycin derivatives
US20020077302A1 (en) 1999-04-23 2002-06-20 Yong-Jin Wu Tricyclic erythromycin derivatives
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
CN1351608A (en) 1999-05-24 2002-05-29 辉瑞产品公司 13-Methylerythromycin Derivatives
EP1114826A3 (en) 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1122261A3 (en) 2000-01-31 2001-09-26 Pfizer Products Inc. 13 and 14-membered antibacterial macrolides
EP1146051A3 (en) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020061856A1 (en) 2000-04-24 2002-05-23 Yong-Jin Wu Novel tricyclic erythromycin derivatives
PT1167376E (en) 2000-06-30 2004-09-30 Pfizer Prod Inc MACROLIDOS ANTIBIOTICS
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
AU2002230386A1 (en) 2000-09-25 2002-04-29 Kosan Biosciences, Inc. Sixteen-membered macrolide compounds

Also Published As

Publication number Publication date
AR020032A1 (en) 2002-03-27
US20030229031A1 (en) 2003-12-11
AU3832100A (en) 2000-12-12
OA11945A (en) 2006-04-13
EP1180110A1 (en) 2002-02-20
IS6128A (en) 2001-10-26
NO20015172D0 (en) 2001-10-23
HUP0201516A3 (en) 2003-03-28
KR20020016799A (en) 2002-03-06
EA200100983A1 (en) 2002-10-31
CZ20013733A3 (en) 2002-11-13
BR0010938A (en) 2002-03-19
HUP0201516A2 (en) 2002-08-28
TNSN00108A1 (en) 2002-05-30
ZA200109595B (en) 2003-05-28
UY26161A1 (en) 2000-12-29
TR200103395T2 (en) 2002-04-22
CN1351608A (en) 2002-05-29
PE20010171A1 (en) 2001-02-10
PA8495101A1 (en) 2002-08-26
JP2003500414A (en) 2003-01-07
IL145739A0 (en) 2002-07-25
HK1045523A1 (en) 2002-11-29
MA26740A1 (en) 2004-12-20
EE200100613A (en) 2003-02-17
AP2001002302A0 (en) 2001-10-25
SK15162001A3 (en) 2003-02-04
WO2000071557A1 (en) 2000-11-30
PL352720A1 (en) 2003-09-08
DZ3045A1 (en) 2004-03-27
HRP20010866A2 (en) 2003-06-30
US6777543B2 (en) 2004-08-17
CA2373117A1 (en) 2000-11-30
CA2373117C (en) 2006-02-28
BG106127A (en) 2002-05-31
US20030100518A1 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
NO20015172L (en) 1-methyl-erythromycin derivatives
NO996108L (en) 9 oksinerytromycinderivater
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
NO20051303L (en) New benzoimidazole derivatives useful as antiproliferative agents
SE9903760D0 (en) New compounds
DK0734383T3 (en) Cyclic amide derivatives as neurokinin A antagonists
NO20085077L (en) New connections
WO2002080846A3 (en) Epothilone derivatives and methods for making and using the same
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
ES2196331T3 (en) MACROCICLICAL CHAIN DERIVATIVES OF 13 ELEMENTS OF ERYTHROMYCINS A AND B.
DE60039238D1 (en) C-2-MODIFIED ERYTHROMYCIN DERIVATIVES
DE602004011966D1 (en) Heterocyclylverbindungen
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
NO20052074L (en) Substituted benzoxazinones and uses thereof.
NO20064010L (en) Indazole derivatives and pharmaceutical preparations contain such
NO20020282D0 (en) New diphenylpiperidine derivative
PT992509E (en) NEW MACROLIDED DERIVATIVES
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
EP1277744A4 (en) Oxadiazole derivatives having anticancer effects
NO20052182L (en) New connections
EP1109560A4 (en) Compounds useful as aicarft inhibitors
WO2003047505A3 (en) Topoisomerase poison agents
NO20022123L (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
NO20030061D0 (en) Tyrosine derivatives as phosphatase inhibitors
NO20065873L (en) 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxoazolidin-2-one derivatives as MAO inhibitors in the treatment of bacterial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application